Vimarsana
Biggest News Aggregation in the World

Page 7 - Director Beth News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Director Beth. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Director Beth Today - Breaking & Trending Today

Taste of Two Towns fundraiser returns to Oakmont library - Vimarsana News

Taste of Two Towns fundraiser returns to Oakmont library

Restaurants and breweries from Oakmont and Verona will come together in support of their local library. The Oakmont Carnegie Library will host A Taste of Two Towns fundraiser on Sunday, May 7. Patrons can sample items from more than a dozen places. There will be door prizes and raffles, too.

WAXE Self Reported Market Capitalization Tops $328.55 Million (WAXE) - Vimarsana News

WAXE Self Reported Market Capitalization Tops $328.55 Million (WAXE)

Should You Buy or Sell Vera Therapeutics Stock? Get The Latest VERA Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $22.00 - Vimarsana News

Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $22.00

Vera Therapeutics (NASDAQ:VERA – Get Rating) had its target price dropped by research analysts at JPMorgan Chase & Co. from $38.00 to $22.00 in a research report issued on Wednesday, Benzinga reports. The firm currently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential upside of 253.13% […]

Source: wkrb13.com
Beth C. Seidenberg Buys 2,300 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock - Vimarsana News

Beth C. Seidenberg Buys 2,300 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) Stock

Vera Therapeutics, Inc. (NASDAQ:VERA – Get Rating) Director Beth C. Seidenberg acquired 2,300 shares of the firm’s stock in a transaction that occurred on Thursday, March 30th. The stock was acquired at an average price of $7.24 per share, with a total value of $16,652.00. Following the completion of the transaction, the director now directly […]

Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $11.00 - Vimarsana News

Vera Therapeutics (NASDAQ:VERA) Price Target Cut to $11.00

Vera Therapeutics (NASDAQ:VERA – Get Rating) had its target price trimmed by HC Wainwright from $15.00 to $11.00 in a research report released on Wednesday, The Fly reports. The firm currently has a buy rating on the stock. HC Wainwright also issued estimates for Vera Therapeutics’ Q1 2023 earnings at ($0.70) EPS, Q2 2023 earnings […]